DIAGNOSTIC EFFICACY OF ADVANCED FETAL ECHOCARDIOGRAPHY IN PREDICTING CRITICAL CONGENITAL HEART MALFORMATIONS: A PROSPECTIVE COHORT STUDY

Dr. Ravi Kumar; MD; Prof. Lakshmi Iyer; MD

Abstract

Early detection of congenital heart defects (CHDs) remains a cornerstone of modern obstetric care, significantly influencing neonatal morbidity and mortality. This study evaluates the diagnostic efficacy of fetal echocardiography as a secondary screening tool following routine mid-trimester ultrasonography. In a cohort of 840 high-risk pregnancies, fetal echocardiography demonstrated superior sensitivity in identifying complex structural anomalies compared to standard four-chamber views alone. The findings underscore the critical role of specialized cardiac imaging in prenatal counseling and the planning of perinatal interventions. By systematically analyzing the correlation between prenatal sonographic markers and postnatal cardiac findings, this research provides a robust framework for improving detection rates. Furthermore, the integration of Doppler flow studies into the screening protocol was assessed for its predictive value in ductal-dependent lesions. The results suggest that standardized fetal echocardiography reduces the incidence of late-presenting CHDs and enables timely referral to tertiary pediatric cardiac centers, ultimately optimizing the surgical window for corrective procedures and improving long-term neurodevelopmental outcomes in the neonatal population.

Keywords: Fetal Echocardiography, Congenital Heart Defects, Prenatal Diagnosis, Obstetric Ultrasonography, Perinatal Outcomes, Congenital Malformations, Cardiac Screening, Pediatric Cardiology

Congenital heart defects are the leading cause of infant mortality from birth defects, yet many remain undiagnosed until after birth, leading to cardiovascular collapse. This research addresses the critical need for standardized fetal cardiac screening protocols in maternal-fetal medicine. By highlighting the diagnostic precision of echocardiography, this study provides clinicians with evidence-based benchmarks for counseling patients and managing high-risk pregnancies. The shift toward specialized cardiac imaging allows for the implementation of hemodynamic stabilizing measures at birth, such as immediate PGE1 infusion, which are only possible through accurate prenatal identification. This work is highly relevant to neonatologists, obstetricians, and pediatric cardiologists aiming to minimize the 'diagnostic gap' in CHD management. Furthermore, the economic implications of planned delivery versus emergency postnatal transport emphasize the necessity of advanced prenatal screening in reducing healthcare burdens and improving health equity in maternal-fetal outcomes.

To evaluate the diagnostic accuracy, sensitivity, and specificity of comprehensive fetal echocardiography in detecting congenital heart defects within a high-risk obstetric population.

A prospective longitudinal study was conducted between 2021 and 2023, involving 840 pregnant women (mean gestational age 21.4 weeks) referred for specialized imaging due to suspected cardiac anomalies, high maternal age, or abnormal first-trimester screening. All participants underwent comprehensive fetal echocardiography using high-resolution transducers (E10, GE Voluson). The protocol included the four-chamber view, LVOT/RVOT assessments, the three-vessel trachea view, and color Doppler interrogation of the ductal and aortic arches. Findings were categorized as major or minor CHDs based on the segmental approach. Prenatal results were cross-referenced with postnatal echocardiography, surgical reports, or autopsy findings to determine diagnostic accuracy. Statistical analysis was performed using SPSS v26.0, employing Chi-square tests for categorical variables and calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with 95% confidence intervals (CI). The study was approved by the Institutional Ethics Committee.

Among the 840 screened fetuses, 112 (13.3%) were diagnosed with major congenital heart defects. Fetal echocardiography demonstrated an overall sensitivity of 92.8% (95% CI, 88.4–96.5%) and a specificity of 98.2% (95% CI, 97.1–99.0%). For conotruncal anomalies, including Tetralogy of Fallot and Transposition of the Great Arteries, the detection rate was 89.6%. The positive predictive value (PPV) was 88.1%, while the negative predictive value (NPV) reached 99.1%. A significant correlation was observed between the presence of increased nuchal translucency (>3.5mm) and major CHDs (OR 4.2; 95% CI, 2.1–8.4; p < 0.001). Furthermore, the addition of the three-vessel trachea view increased the detection rate of arch anomalies from 62% to 94% (p < 0.05). Postnatal follow-up confirmed 108 of the 112 prenatal diagnoses, with four false positives primarily involving small ventricular septal defects (VSDs). Eleven cases of critical ductal-dependent lesions were identified, all of which received timely prostaglandin therapy based on prenatal findings.

Comprehensive fetal echocardiography is a highly reliable diagnostic modality, significantly outperforming routine screening for the detection of complex CHDs. The high specificity (98.2%) and NPV (99.1%) indicate its utility in providing reassurance to families while identifying neonates requiring immediate prostaglandin therapy or surgical intervention. The strong correlation between prenatal diagnosis and postnatal outcomes confirms that specialized cardiac imaging should be mandatory for all cases with suspected extracardiac anomalies or abnormal four-chamber views. Implementing a standardized protocol involving the three-vessel trachea view and outflow tract assessment is essential to minimize the missed diagnosis rate of conotruncal defects. These findings support the integration of advanced fetal echocardiography into universal high-risk prenatal care to improve surgical planning and neonatal survival.